Background/Aim: Extracellular vesicles (exosomes, EVs) (30-200 nm in diameter) are secreted by various cells in the body. Owing to the pharmaceutical advantages of EVs, an EV-based drug delivery system (DDS) for cancer therapy is expected to be the next-generation therapeutic system. However, preservation methods for functional and therapeutic EVs should be developed. Here, we developed the method of lyophilization of arginine-rich cell penetrating peptide (CPP)modified EVs and investigated the effects of lyophilization on the characteristics of EVs. Materials and Methods: Particle size, structure, zeta-potential, and cellular uptake efficacy of the arginine-rich CPP-modified EVs were analyzed. The model protein saporin (SAP), having anti-cancer effects, was encapsulated inside the EVs to assess the cytosolic release of EV content after cellular uptake. Results: Lyophilization of the EVs did not affect their particle size, structure, zeta-potential, and cellular uptake efficacy; however, the biological activity of the encapsulated SAP was inhibited by lyophilization. Conclusion: Lyophilization of EVs may affect SAP structures and/or reduce the cytosolic release efficacy of EV’s content after cellular uptake and needs attention in EV-based DDSs.
CITATION STYLE
Noguchi, K., Hirano, M., Hashimoto, T., Yuba, E., Takatani-Nakase, T., & Nakase, I. (2019). Effects of lyophilization of arginine-rich cell-penetrating peptide-modified extracellular vesicles on intracellular delivery. Anticancer Research, 39(12), 6701–6709. https://doi.org/10.21873/anticanres.13885
Mendeley helps you to discover research relevant for your work.